{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-082077","form_type":"8-K","ticker":"ORIC","cik":"0001796280","company_name":"Oric Pharmaceuticals, Inc.","filed_at":"2024-03-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.563038+00:00","generated_at":"2026-06-04T05:30:11.668085+00:00","sec_items":["5.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"ORIC Pharma boosts inducement equity plan by 650k shares to 1.15M total","bullets":["Compensation Committee approved amended 2022 Inducement Plan, adding 650,000 shares.","Total shares reserved under plan now 1,150,000, for equity grants to new employees.","Plan adopted without stockholder approval per Nasdaq inducement award rules.","Awards may only go to individuals not previously employees/directors, as hiring inducement.","Effective March 26, 2024; plan terms substantially similar to 2020 Equity Incentive Plan."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-082077","json":"https://secwatch.observer/filing/0001193125-24-082077.json","markdown":"https://secwatch.observer/filing/0001193125-24-082077.md","text":"https://secwatch.observer/filing/0001193125-24-082077.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1796280/000119312524082077/0001193125-24-082077-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1796280/000119312524082077/d802175d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T05:30:11.668085+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}